By Tom Crosby, RESI Conference Manager, LSN
Last week, LSN announced the RESI Conference’s new Commercializing Medtech Innovation panel, which will bring insights from investors who focus on devices that are nearing commercialization. This week, LSN is proud to announce another brand new panel in the Medtech Investor Panels track — this time, featuring investors who focus on earlier-stage opportunities. The In Development / Clinical Investors Medtech panel will offer viewpoints and advice from a diverse group of investors.
Moderated by Vicki Anastasi, Vice President & Global Head of Medical Device and Diagnostic Research at ICON, the audience will hear from:
Cary Adams, Founder, Almond Tree Capital
Jeff Sheldon, Managing Director, CitareTX
Ibraheem Badejo, Senior Director, New Ventures, Johnson & Johnson Innovation
Doug Fisher, Partner, InterWest Partners
Panelists will share their opinions on why medical device investments have been surging in 2014, and how entrepreneurs can capitalize on the trend. What is the path of least resistance from prototype to allocation? How do device entrepreneurs identify and qualify organizations that are actively investing early? What are the pros and cons of taking a venture capital investment, and what are the roles of other sources of funding? With a panel drawn from a wide variety of backgrounds, the session will offer an interesting perspective for any device company looking to take its technology to the next level.
Next Phase Newsletter 
Leave a comment